TrialJournal of diabetes2022

Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.